Literature DB >> 2049371

Interactions of iprindole with fenfluramine metabolism in rat brain and liver.

K M Hegadoren1, G B Baker, R T Coutts, W G Dewhurst.   

Abstract

An assay procedure utilizing electron-capture gas chromatography was developed for simultaneous analysis of fenfluramine and norfenfluramine. This method was applied to brain and liver samples from rats which had been injected with fenfluramine with or without pretreatment with iprindole. The tissues from rats treated with fenfluramine showed extensive formation of norfenfluramine, consistent with findings reported previously in the literature. Pretreatment with iprindole led to an increase in brain and liver levels of fenfluramine, and, unexpectedly, to a marked decrease in levels of norfenfluramine in these tissues. These findings suggest that iprindole blocks N-deethylation and that it may be a useful tool with which to study the effects of fenfluramine in the absence of norfenfluramine. The results also emphasize the importance of considering drug-drug interactions in future research on fenfluramine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2049371      PMCID: PMC1188281     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  26 in total

1.  Fenfluramine treatment of autism: UCLA collaborative study of 81 patients at nine medical centers.

Authors:  E R Ritvo; B J Freeman; A Yuwiler; E Geller; P Schroth; A Yokota; A Mason-Brothers; G J August; W Klykylo; B Leventhal
Journal:  Psychopharmacol Bull       Date:  1986

2.  The neuroendocrine response to fenfluramine in depressives and normal controls.

Authors:  G M Asnis; J Eisenberg; H M van Praag; C Z Lemus; J M Friedman; A H Miller
Journal:  Biol Psychiatry       Date:  1988-05       Impact factor: 13.382

3.  Fenfluramine metabolism.

Authors:  R B Bruce; W R Maynard
Journal:  J Pharm Sci       Date:  1968-07       Impact factor: 3.534

4.  Effect of monoamine oxidase inhibitors on the N-demethylation and hydrolysis of meperidine.

Authors:  N R Eade; K W Renton
Journal:  Biochem Pharmacol       Date:  1970-07       Impact factor: 5.858

Review 5.  Neurobiology of an anorectic drug: fenfluramine.

Authors:  N E Rowland; J Carlton
Journal:  Prog Neurobiol       Date:  1986       Impact factor: 11.685

6.  Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression.

Authors:  L J Siever; D L Murphy; S Slater; E de la Vega; S Lipper
Journal:  Life Sci       Date:  1984-03-12       Impact factor: 5.037

7.  Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine.

Authors:  M S Kleven; C R Schuster; L S Seiden
Journal:  J Pharmacol Exp Ther       Date:  1988-09       Impact factor: 4.030

8.  Metabolism of fenfluramine to norfenfluramine in guinea-pigs.

Authors:  R W Fuller; H D Snoddy; K W Perry
Journal:  J Pharm Pharmacol       Date:  1988-06       Impact factor: 3.765

9.  Disposition of (-)-fenfluramine and its active metabolite, (-)-norfenfluramine in rat: a single dose-proportionality study.

Authors:  R Spinelli; C Fracasso; G Guiso; S Garattini; S Caccia
Journal:  Xenobiotica       Date:  1988-05       Impact factor: 1.908

10.  Pharmacokinetics of fenfluramine and norfenfluramine in volunteers given D- and DL-fenfluramine for 15 days.

Authors:  S Caccia; I Conforti; J Duchier; S Garattini
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

View more
  2 in total

Review 1.  Metabolism of some "second"- and "fourth"-generation antidepressants: iprindole, viloxazine, bupropion, mianserin, maprotiline, trazodone, nefazodone, and venlafaxine.

Authors:  S Rotzinger; M Bourin; Y Akimoto; R T Coutts; G B Baker
Journal:  Cell Mol Neurobiol       Date:  1999-08       Impact factor: 5.046

2.  Effect of iprindole on the metabolism of trimipramine in the rat.

Authors:  R T Coutts; M S Hussain; G B Baker
Journal:  J Psychiatry Neurosci       Date:  1991-12       Impact factor: 6.186

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.